Rosiglitazone decreases albuminuria in type 2 diabetic patients

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 100%
• Glucose 100%
• Rosiglitazone 100%
• Albuminuria 75%
• Tumor Necrosis Factor 75%
• Adiponectin 75%
• Insulin 50%
• Fatty Acid 50%
• Placebo 50%
• Albumin 25%
• Lipid 25%
• Kidney Disease 25%
• Creatinine 25%
• Fat 25%

Neuroscience

• Rosiglitazone 100%
• Free Fatty Acids 100%
• Adiponectin 75%
• Tumor Necrosis Factor Alpha 75%
• Insulin 50%
• Glucose 50%
• Thiazolidinedione 50%
• Placebo 50%
• Regression Analysis 25%
• Creatinine 25%
• Albumin 25%

Biochemistry, Genetics and Molecular Biology

• Rosiglitazone 100%
• Tumor Necrosis Factors 75%
• Adiponectin 75%
• Insulin 50%
• Glucose 50%
• Glucose Blood Level 50%
• Thiazolidinedione 50%
• Metabolic Clearance Rate 50%
• Creatinine 25%
• Lipid Profile 25%
• Fat Mass 25%